Reduction of Cardiac Fibrosis by Interference With YAP-Dependent Transactivation

Circ Res

12 Luglio Lug 2022 5 months ago
  • Garoffolo G, Casaburo M, Amadeo F, G, Piacentini L, Zuccolo E, Agrifoglio M, Ragazzini S, Chiesa M, Ferrari S, Santoro R, Manzoni M, Raucci A.

Conversion of cardiac stromal cells into myofibroblasts is typically associated with hypoxia conditions, metabolic insults, and/or inflammation, all of which are predisposing factors to cardiac fibrosis and heart failure. We hypothesized that this conversion could be also mediated by response of these cells to mechanical cues through activation of the Hippo transcriptional pathway. The objective of the present study was to assess the role of cellular/nuclear straining forces acting in myofibroblast differentiation of cardiac stromal cells under the control of YAP (yes-associated protein) transcription factor and to validate this finding using a pharmacological agent that interferes with the interactions of the YAP/TAZ (transcriptional coactivator with PDZ-binding motif) complex with their cognate transcription factors TEADs (TEA domain transcription factors), under high-strain and profibrotic stimulation.

Reference: Reduction of Cardiac Fibrosis by Interference With YAP-Dependent Transactivation.
Garoffolo G, Casaburo M, Amadeo F, Salvi M, Bernava G, Piacentini L, Chimenti I, Zaccagnini G, Milcovich G, Zuccolo E, Agrifoglio M, Ragazzini S, Baasansuren O, Cozzolino C, Chiesa M, Ferrari S, Carbonaro D, Santoro R, Manzoni M, Casalis L, Raucci A, Molinari F, Menicanti L, Pagano F, Ohashi T, Martelli F, Massai D, Colombo GI, Messina E, Morbiducci U, Pesce M.
Circ Res. 2022 Jun 30:101161CIRCRESAHA121319373.

Go to PubMed